XML 130 R111.htm IDEA: XBRL DOCUMENT v3.24.3
Share-Based Compensation - Schedule of Options Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Sep. 27, 2024
USD ($)
$ / shares
shares
TBOs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning Shares Outstanding (in shares) 6,600
Granted (in shares) 1,151
Exercised (in shares) (1,808)
Forfeited and expired (in shares) (234)
Awards transferred to Vestis at spin-off (in shares) (355)
Adjustments to Aramark awards related to the spin-off of Vestis (in shares) 2,553
Ending Shares Outstanding (in shares) 7,907
Shares exercisable (in shares) 5,704
Shares Expected to Vest (in shares) 1,971
Weighted-Average Exercise Price  
Beginning Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 35.36
Granted (in dollars per share) | $ / shares 28.17
Exercised (in dollars per share) | $ / shares 23.63
Forfeited and expired (in dollars per share) | $ / shares 28.91
Awards transferred to Vestis at spin-off (in dollars per share) | $ / shares 27.34
Adjustments to Aramark awards related to the spin-off of Vestis (in dollars per share) | $ / shares
Ending Weighted-Average Exercise Price (in dollars per share) | $ / shares 26.14
Weighted average exercise price, exercisable (in dollars per share) | $ / shares 25.34
Expected to vest Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 28.16
Aggregate Intrinsic Value  
Aggregated Intrinsic Value of Shares Outstanding | $ $ 97,284
Aggregate Intrinsic Value, Exercisable | $ 74,707
Aggregate Intrinsic Value of Shares Expected to Vest | $ $ 20,250
Weighted-Average Remaining Term of Shares Outstanding 5 years 10 months 24 days
Weighted average remaining contractual term, Excercisable 5 years
Weighted-Average Remaining Term of Shares Expected to Vest 8 years 4 months 24 days
TBO-Rs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning Shares Outstanding (in shares) 5,222
Exercised (in shares) (27)
Adjustments to Aramark awards related to the spin-off of Vestis (in shares) 2,021
Ending Shares Outstanding (in shares) 7,216
Shares exercisable (in shares) 4,802
Shares Expected to Vest (in shares) 2,318
Weighted-Average Exercise Price  
Beginning Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 66.15
Exercised (in dollars per share) | $ / shares 32.45
Ending Weighted-Average Exercise Price (in dollars per share) | $ / shares 47.75
Weighted average exercise price, exercisable (in dollars per share) | $ / shares 47.78
Expected to vest Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 47.70
Aggregate Intrinsic Value  
Aggregated Intrinsic Value of Shares Outstanding | $ $ 13,011
Aggregate Intrinsic Value, Exercisable | $ 8,621
Aggregate Intrinsic Value of Shares Expected to Vest | $ $ 4,216
Weighted-Average Remaining Term of Shares Outstanding 5 years 8 months 12 days
Weighted average remaining contractual term, Excercisable 5 years 8 months 12 days
Weighted-Average Remaining Term of Shares Expected to Vest 5 years 8 months 12 days